Richard De Abreu Lourenço

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

Michael S. Hofman, Declan G. Murphy, Scott Williams et al. · British Journal of Urology · 2018 · 118 citations · Full text

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

Shankar Siva, Mathias Bressel, Mark Sidhom et al. · The Lancet Oncology · 2024 · 93 citations

Urology, Surgical Oncology, Radiation Therapy +7

Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

Rafael Emilio de Feria Cardet, Michael S. Hofman, Tatiana Segard et al. · European Urology · 2020 · 90 citations · Full text

Urology, Surgical Oncology, Oncologic Imaging +8

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)

Shankar Siva, Mathias Bressel, Tao Mai et al. · JAMA Oncology · 2021 · 84 citations · Full text

Carrots and sticks—the fall and fall of private health insurance in Australia

Jane Hall, Richard De Abreu Lourenço, Rosalie Viney · Health Economics · 1999 · 70 citations · Full text

Health Reform, Health Insurance Design, Financial Protection +18